alzheimers Tag

04 Jul Two copies of gene found to be underlying cause in Alzheimer’s Disease – are you Destiny’s Child?

Posted at 11:17h in Alzheimer’s, Asset Protection, Beneficiary, Dementia, End of Life Care Planning, Estate Planning, Guardianship, Long Term Care, Medicaid Application, Medicaid Planning, Michael Cohen Dallas Elder Lawyer, Nursing Home, Power of Attorney, Probate Administration, Public Benefits Protection

Researchers have found that people with 2 copies of the APOE4 gene is more than a risk factor – it is now considered an underlying cause of Alzheimer’s Disease. Prior to the research’s finding published in May, scientists knew the gene APOE4 increased risk. Although...

29 Sep Donanemab – The Next New Drug Likely To Be Approved In Slowing Memory Decline

Posted at 11:17h in Alzheimer’s, Estate Planning, Medicaid Application, Medicaid Planning, Michael Cohen Dallas Elder Lawyer, Probate Administration, Quality of Life

Earlier this year, leqembi (a drug that slows memory decline for those in the early stages of Alzheimer’s Disease by targeting the amyloid protein, usually common with those inflicted with Alzheimer’s as it begins to form) was approved by both FDA and CMS (governmental assistance...

26 Jul FDA Grants Approval for Drug that Slows Memory Loss

Posted at 13:33h in Alzheimer’s, Dementia, End of Life Care Planning, Estate Planning, Medicaid Application, Medicaid Planning, Medicare, Michael Cohen Dallas Elder Lawyer, Probate Administration

A milestone event in the fight against Alzheimer’s Disease occurred on July 6 when the FDA gave approval for a drug (Leqembi) that not only slows memory loss for those with Alzheimer’s Disease, but it was granted funding approval by the Centers for Medicare &...

07 Sep Gut Reaction – Your Gut Health May Affect Your Brain Health

Posted at 12:46h in Alzheimer’s, Estate Planning, Medicaid Planning, Michael Cohen Dallas Elder Lawyer, Probate Administration

Recent research and studies have shown a genetic link between Alzheimer’s Disease and gastrointestinal tract disorders. Although this doesn’t necessarily mean that gut disorders cause Alzheimer’s Disease, it does indicate that people with gut disorders may be at greater risk of developing Alzheimer’s Disease. As...

17 Jun ALZHEIMER’S DRUG APPROVAL BRINGS HOPE

Posted at 16:25h in Alzheimer’s, Dementia, Estate Planning, Medicaid Planning, Medicare, Michael Cohen Dallas Elder Lawyer, Probate Administration

The FDA has recently approved the medication Aducanumab (which is to be given by infusion every four weeks) that studies have shown to slow the decline of cognitive and functional ability of patients (particularly if in the early stages after a diagnosis or those with...

03 Aug BLOOD TEST TO DETERMINE ALZHEIMER’S DISEASE COULD BE READY IN 2 YEARS

Posted at 20:09h in Alzheimer’s, End of Life Care Planning, Estate Planning, Long Term Care, Michael Cohen Dallas Elder Lawyer

It was recently announced that a simple blood test could be effective in diagnosing Alzheimer’s Disease (even if the person seemed normal) 20 years before memory and thinking problems are to be expected in people with a genetic mutation that causes Alzheimer’s. Although the blood test...

28 Oct HOUSE PASSES KEY PROVISIONS OF YOUNGER-ONSET ALZHEIMER’S DISEASE ACT AND PALLIATIVE CARE AND HOSPICE EDUCATION TRAINING ACT

Posted at 09:00h in Alzheimer’s, Dementia, Long Term Care, Quality of Life

The House of Representatives, with bipartisan support, passed two bills on October 28 that are important to those impacted by Alzheimer’s disease. The Palliative Care and Hospice Education and Training Act (PCHETA) increases the availability and quality of care by creating hospice workforce and palliative...

29 Sep SENATE SUBCOMMITTEE PROPOSED $350 MILLION INCREASE FOR ALZHEIMER’S AND DEMENTIA RESEARCH

Posted at 15:16h in Alzheimer’s, Dementia, End of Life Care Planning, Estate Planning

The Senate Labor-HHS Appropriations Subcommittee has proposed a $350 million increase, raising the total to $2.8 billion annually if passed into law, for research funding on Alzheimer’s and dementia for year 2020. The Senate Subcommittee saw the progress in dementia research being made by researchers...

03 Sep QUEEN OF SWEDEN AND IKEA PARTNERSHIP TO HELP PEOPLE WITH DEMENTIA

Posted at 09:00h in Alzheimer’s, Assisted Living, Dementia, Long Term Care, Nursing Home

In an effort to make it easier for those suffering dementia to live independently instead of going to a nursing home, the Queen of Sweden (Queen Silvia), furniture maker Ikea, along with Skanska (a Swedish construction company) are teaming up to provide comfortable living solutions....

06 Aug LARGE GRANT GIVEN TO DETERMINE IF LIFESTYLE INTERVENTION REDUCES ALZHEIMER’S RISK

Posted at 15:00h in Alzheimer’s, Dementia

The U.S. National Institute of Aging (NIA) is giving the University of California, Berkley a five year grant expected to total $47 million to determine whether lifestyle changes will reduce the risk of developing Alzheimer’s disease. The study will be used to determine if lifestyle interventions...